CG Oncology develops cretostimogene, an investigational bladder cancer immunotherapy given directly into the bladder. It last closed at $78.94 on Nov 17, down 6.89% on the day. The average 12-month price target from 7 analysts is $95.71 (+21.2% from the last close), with a high of $115.00 and a low of $65.00. Analyst consensus is Strong Buy, based on the latest ratings from 7 firms (6 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 9 whale options trades in CGON, 78% of them bullish and 22% bearish. In the past 30 days there were 6 dark pool prints totaling $5.3M, the largest $1.3M.
Each firm's latest rating on CGON in the past 90 days
Average 12-month target
$95.71
▲ 21.2% upside
Based on 7 analysts who set a price target on CGON in the past 90 days. The average target is $95.71, with a high of $115.00 and a low of $65.00, compared with the last close of $78.94.
Highest target$115.00
Average target$95.71
Lowest target$65.00
Latest rating changes
JP MorganMaintained
Nov 17Buy$113
Truist SecuritiesTarget raised
Nov 17Buy$85 → $100
RBC CapitalDowngrade
Nov 17Hold$97
WedbushTarget raised
Nov 17Buy$84 → $91
HC Wainwright & Co.Maintained
Nov 17Buy$115
Date
Firm
Action
Rating
Price target
Nov 17
JP Morgan
Maintained
Buy
$113
Nov 17
Truist Securities
Target raised
Buy
$85 → $100
Nov 17
RBC Capital
Downgrade
Hold
$97
Nov 17
Wedbush
Target raised
Buy
$84 → $91
Nov 17
HC Wainwright & Co.
Maintained
Buy
$115
Loading…
Technical Analysis
CGON · as of the Nov 17 close · updated after every close
Uptrend
The stock is 13% above its 20 day and 13% above its 50 day average. It is 15% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 62). The nearest support is the Pivot at $78.45, and the nearest resistance the swing high (Sep 2) at $79.23.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 7.4%/day
Key levels
$93.9552 week high+19.0%
$83.46Pivot R1+5.7%
$79.23Swing high (Sep 2)+0.4%
$78.94Last close
$78.45Pivot−0.6%
$73.94Pivot S1−6.3%
$73.50Swing low (Aug 14)−6.9%
$71.02100 day average−10.0%
$68.3550 day average−13.4%
$68.2920 day average−13.5%
$66.96200 day average−15.2%
$37.0152 week low−53.1%
Indicators
RSI (14)
61.68
Strong, overbought above 70
Neutral
MACD
3.26
Above its signal line
Bullish
Stochastic
66.5
Middle of its range
Neutral
ADX (14)
28.2
Trending up
Williams %R
-45.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
119.4
Oversold below −100, overbought above 100
Overbought
Rate of change
+23.2%
Change over 10 sessions
Bullish
ATR (14)
$5.85
Typical daily range, 7.4% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNormal
VolatilityNormal, 11.0%/day
Key levels
$93.9552 week high+19.0%
$83.46Pivot R1+5.7%
$79.23Swing high (Sep 2)+0.4%
$78.94Last close
$78.45Pivot−0.6%
$73.94Pivot S1−6.3%
$73.50Swing low (Aug 14)−6.9%
$71.02100 day average−10.0%
$68.3550 day average−13.4%
$68.2920 day average−13.5%
$66.96200 day average−15.2%
$37.0152 week low−53.1%
Indicators
RSI (14)
61.08
Strong, overbought above 70
Neutral
MACD
2.14
Above its signal line
Bullish
Stochastic
67.9
Middle of its range
Neutral
ADX (14)
24.8
Weak trend
Williams %R
-43.2
Oversold below −80, overbought above −20
Neutral
CCI (20)
177.5
Oversold below −100, overbought above 100
Overbought
Rate of change
+9.1%
Change over 10 sessions
Bullish
ATR (14)
$8.72
Typical daily range, 11.1% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for CGON
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CGON did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Whale flow leans bullish7 bullish and 2 bearish whale options trades in the last 90 days. See Whale Flow
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90D
No whale options trades in CGON in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CGON is in one of them and how their past CGON trades turned out.
CG Oncology is a clinical stage biopharmaceutical company developing cretostimogene, an investigational immunotherapy for bladder cancer. The treatment is delivered directly into the bladder and is being studied in patients with high risk and intermediate risk forms of the disease that have not grown into the muscle wall of the bladder. The company is based in Dallas, Texas, and its intended customers are patients with bladder cancer and the urology practices that treat them.